Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib vs Ketorolac for Postoperative Pain
NCT03331315Phase 2Completed
- Start
- Sep 2013
- Primary completion
- Jun 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of celecoxib in postoperative pain (2 arms). Primary endpoint: Average Inpatient Postoperative Pain Score at 48 hours. Started Sep 2013; status: completed.
02
Drugs
celecoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03331315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03331315.